This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21, to Diacarta, Inc. for reference laboratory testing services to aid in the diagnosis of VEXAS Syndrome. The contract has a total ceiling value of $200,000 and a period of performance from October 1, 2024 to September 30, 2029.
The key services under this contract include specimen pickup, testing for somatic mutations of the UBA1 gene, reporting, and consultation. The contractor must be CLIA-certified and maintain professional liability insurance. An initial 1-year task order worth $19,104 has been awarded, with the option for 4 additional 1-year task orders. The original market research solicitation was not set aside for any business size and sought pricing information, capability statements, and details on any planned subcontracting from interested vendors. The VA's San Francisco VA Health Care System (SFVAHCS) is the intended end-user of these reference lab services.
Generated 10/2/24, 9:18 AM